<div id="readability-page-1"><p>Canopy Partners LLC lessened its holdings in  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 31.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,469 shares of the healthcare conglomerate's stock after selling 1,567 shares during the quarter. Canopy Partners LLC's holdings in UnitedHealth Group were worth $1,082,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>5 Stocks Congress Quietly Bought in Q3—Should You Follow?</li></ul><p>Other hedge funds and other institutional investors have also bought and sold shares of the company. Citizens National Bank Trust Department raised its stake in  UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after acquiring an additional 170 shares in the last quarter.  Fort Washington Investment Advisors Inc. OH raised its stake in  UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after acquiring an additional 1,465 shares in the last quarter.  Caitlin John LLC raised its stake in  UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after acquiring an additional 111 shares in the last quarter.  Triumph Capital Management acquired a new position in  UnitedHealth Group during the second quarter worth about $1,324,000.  Finally, Wealth Effects LLC grew its holdings in shares of  UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock worth $1,463,000 after purchasing an additional 591 shares during the last quarter. Institutional investors and hedge funds own  87.86% of the company's stock. </p><h2>Analyst Upgrades and Downgrades</h2><p>Several research firms have recently weighed in on UNH. Truist Financial boosted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a &#34;buy&#34; rating in a report on Tuesday, September 9th. Baird R W cut UnitedHealth Group from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a report on Thursday, July 31st. Sanford C. Bernstein upped their target price on UnitedHealth Group from $337.00 to $379.00 and gave the company an &#34;outperform&#34; rating in a report on Friday, September 5th. KeyCorp reduced their target price on UnitedHealth Group from $400.00 to $350.00 and set an &#34;overweight&#34; rating on the stock in a report on Wednesday, July 30th. Finally, Barclays upped their target price on UnitedHealth Group from $337.00 to $352.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, September 4th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued  a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of &#34;Hold&#34; and an average price target of $365.00.</p><ul><li>5 Healthcare Plays Powering the Sector’s Big Comeback</li></ul><p><b>Check Out Our Latest Stock Report on UNH</b></p><h2>UnitedHealth Group Price Performance</h2><p>Shares of NYSE:UNH opened at $363.95 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock's 50 day moving average is $311.44 and its 200-day moving average is $352.42. The firm has a market capitalization of $329.62 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 2.33 and a beta of 0.47. </p><ul><li>More Than a Rebound: UnitedHealth Is Back in the Game</li></ul><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year.  UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts forecast that  UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year. </p><h2>UnitedHealth Group Announces Dividend</h2><p>The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio  is presently 38.30%. </p><h2>UnitedHealth Group Company Profile</h2> (Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>What is MarketRank™? How to Use it</li><li>EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector</li><li>Basic Materials Stocks Investing</li><li>These Are the 3 Hottest Sectors for Q3 Earnings Growth</li><li>3 Tickers Leading a Meme Stock Revival</li><li>AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Canopy Partners LLC reduced its stake in UnitedHealth Group (NYSE:UNH) by 31.1% in Q2, selling 1,567 shares, leaving them with 3,469 shares valued at $1,082,000. Other institutional investors also adjusted their holdings. Analysts have mixed ratings on UNH, with a consensus rating of "Hold" and an average price target of $365.00. The stock opened at $363.95, with a market cap of $329.62 billion. UnitedHealth reported Q2 earnings of $4.08 per share, missing estimates, and declared a quarterly dividend of $2.21.</p>

Canopy Partners LLC Sells 1,567 Shares of UnitedHealth Group Incorporated $UNH